PL2303930T3 - Siarczanowany związek polisacharydowy oraz jego wytwarzanie i zastosowanie - Google Patents

Siarczanowany związek polisacharydowy oraz jego wytwarzanie i zastosowanie

Info

Publication number
PL2303930T3
PL2303930T3 PL08800116T PL08800116T PL2303930T3 PL 2303930 T3 PL2303930 T3 PL 2303930T3 PL 08800116 T PL08800116 T PL 08800116T PL 08800116 T PL08800116 T PL 08800116T PL 2303930 T3 PL2303930 T3 PL 2303930T3
Authority
PL
Poland
Prior art keywords
preparation
sulfated polysaccharide
polysaccharide compound
compound
sulfated
Prior art date
Application number
PL08800116T
Other languages
English (en)
Inventor
Vladimir Stajic
Norman Cheetham
Alan Bell
Original Assignee
Parnell Tech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008903436A external-priority patent/AU2008903436A0/en
Application filed by Parnell Tech Pty Ltd filed Critical Parnell Tech Pty Ltd
Publication of PL2303930T3 publication Critical patent/PL2303930T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0057—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Xylans, i.e. xylosaccharide, e.g. arabinoxylan, arabinofuronan, pentosans; (beta-1,3)(beta-1,4)-D-Xylans, e.g. rhodymenans; Hemicellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Sustainable Development (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08800116T 2008-07-04 2008-10-08 Siarczanowany związek polisacharydowy oraz jego wytwarzanie i zastosowanie PL2303930T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008903436A AU2008903436A0 (en) 2008-07-04 A sulfated polysaccharide compound for clinical use and the preparation and use thereof
PCT/AU2008/001481 WO2010000013A1 (en) 2008-07-04 2008-10-08 A sulfated polysaccharide compound and the preparation and use thereof
EP08800116.9A EP2303930B1 (en) 2008-07-04 2008-10-08 A sulfated polysaccharide compound and the preparation and use thereof

Publications (1)

Publication Number Publication Date
PL2303930T3 true PL2303930T3 (pl) 2016-08-31

Family

ID=39748577

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08800116T PL2303930T3 (pl) 2008-07-04 2008-10-08 Siarczanowany związek polisacharydowy oraz jego wytwarzanie i zastosowanie

Country Status (10)

Country Link
US (3) US9120877B2 (pl)
EP (3) EP3059254A3 (pl)
AU (3) AU2008100725B4 (pl)
DK (1) DK2303930T3 (pl)
ES (1) ES2565641T3 (pl)
HU (1) HUE028635T2 (pl)
NZ (3) NZ608738A (pl)
PL (1) PL2303930T3 (pl)
SI (1) SI2303930T1 (pl)
WO (1) WO2010000013A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012101544A1 (en) * 2011-01-29 2012-08-02 Alembic Pharmaceuticals Limited An improved process for the preparation of pentosan polysulfate or salts thereof
WO2012114349A1 (en) * 2011-02-23 2012-08-30 Cadila Healthcare Limited An improved process for the preparation of pentosan polysulfate sodium
CN104370980B (zh) * 2014-10-17 2017-12-01 九芝堂股份有限公司 一种抑制内源性因子x酶活性的寡糖类化合物及其药物组合物
RU2620595C1 (ru) * 2016-06-22 2017-05-29 Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр "Красноярский научный центр Сибирского отделения Российской академии наук" (ФИЦ КНЦ СО РАН) Способ сульфатирования ксилана древесины берёзы
RU2620597C1 (ru) * 2016-06-22 2017-05-29 Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр "Красноярский научный центр Сибирского отделения Российской академии наук" (ФИЦ КНЦ СО РАН) Способ сульфатирования ксилана древесины берёзы сульфаминовой кислотой
JPWO2018043667A1 (ja) * 2016-08-31 2018-08-30 王子ホールディングス株式会社 酸性キシロオリゴ糖の製造方法及び酸性キシロオリゴ糖
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
CN110678189A (zh) 2017-05-31 2020-01-10 王子控股株式会社 保湿外用剂
EP3683242B1 (en) 2017-09-12 2024-10-30 Oji Holdings Corporation Pentosan polysulfate and method for producing pentosan polysulfate
CA3086301C (en) * 2017-12-20 2025-04-08 Oji Holdings Corporation PENTOSANNE POLYSULFATE AND MEDICINE CONTAINING PENTOSANNE POLYSULFATE
CA3089077A1 (en) 2018-02-16 2019-08-22 Proteobioactives Pty Limited Methods and compositions for the treatment of pain and/or inflammation
CN109793751B (zh) * 2019-01-15 2021-02-26 广西壮族自治区中国科学院广西植物研究所 阿拉伯木聚糖磺酸盐在制备治疗骨关节炎的药物中的应用
CN114835833A (zh) * 2022-06-13 2022-08-02 南通职业大学 一种水稻秸秆木聚糖硫酸酯、制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2689848A (en) * 1951-02-06 1954-09-21 Wander Ag Dr A Salts of sulfuric acid esters of xylan
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US5180715A (en) 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen
ATE129254T1 (de) * 1987-03-19 1995-11-15 Arthropharm Pty Ltd Antientzündungsmittel und zusammensetzungen.
DE3921761A1 (de) * 1989-07-01 1991-01-03 Hoechst Ag Substituierte polysaccharide, verfahren zu deren herstellung sowie deren verwendung zur prophylaxe und behandlung von viruserkrankungen
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
IT1290814B1 (it) 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US7067144B2 (en) 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
WO2001052867A1 (en) 2000-01-19 2001-07-26 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of pentosan polysulfate to treat certain conditions of the prostate
US6593310B1 (en) * 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
NZ571537A (en) 2006-04-03 2012-06-29 Nutramax Lab Inc Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them
WO2009047699A1 (en) 2007-10-10 2009-04-16 Alembic Limited An improved process for the preparation of an amorphous form of pentosan polysulfate or salts thereof

Also Published As

Publication number Publication date
WO2010000013A1 (en) 2010-01-07
US9120877B2 (en) 2015-09-01
AU2008100730A4 (en) 2008-09-11
AU2008358975A1 (en) 2010-01-07
EP2303930A4 (en) 2014-08-13
EP2303930A1 (en) 2011-04-06
US20170121428A1 (en) 2017-05-04
NZ608738A (en) 2014-08-29
US20110251154A1 (en) 2011-10-13
AU2008358975B2 (en) 2013-05-02
DK2303930T3 (en) 2016-03-21
NZ624749A (en) 2015-07-31
EP3059254A3 (en) 2016-10-19
EP3059253A2 (en) 2016-08-24
EP2303930B1 (en) 2016-02-17
AU2008358975B9 (en) 2013-06-27
NZ590725A (en) 2013-05-31
US20150080332A1 (en) 2015-03-19
HUE028635T2 (en) 2016-12-28
AU2008100730B4 (en) 2008-10-02
SI2303930T1 (sl) 2016-07-29
AU2008100725B4 (en) 2008-10-02
ES2565641T3 (es) 2016-04-06
AU2008100725A4 (en) 2008-09-11
HK1156333A1 (zh) 2012-06-08
EP3059253A3 (en) 2016-10-19
EP3059254A2 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
SI2303930T1 (sl) Sulfatirana polisaharidna spojina in priprava ter uporaba le-te
AP2630A (en) Antiviral composition comprising a sulfated polysaccharide
EP2236578A4 (en) NOVEL WOOD GLUE ADHESIVE AND CORRESPONDING PREPARATION METHOD
PL2291505T3 (pl) Stały zestaw pielęgnujący tekstylia, zawierający polisacharyd
ZA201201218B (en) 3-polylysine conjugates and the use thereof
IL195937A0 (en) Glucan preparation
IL254218A0 (en) Pipedrine-bridged compounds of the quinoxaline-converted type and their use
HUE037323T2 (hu) Törlõkar-törlõlapát összekapcsolás, valamint törlõlapát
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
IL199819A0 (en) Cable-free arthroendoscope
GB0808575D0 (en) Compilign and linking
PL2011816T4 (pl) Ko-sieciowany żel polisacharydowy
GB0718263D0 (en) Polysaccharide derived mesoporous materials
EP2307052A4 (en) ANTI-BETA-2-MICROGLOBULIN AGENTS AND THEIR USE
EP1978056A4 (en) HYDROXYALKYLATED CHITOSAN-INCLUDING SOLUTION
GB0718718D0 (en) Compound and use thereof
EP2192122A4 (en) DITHIOLOPYRROLON COMPOUNDS, THEIR PREPARATION AND THEIR USE
EP2147676A4 (en) ALLERGENDESAKTIVATOR
GB0721435D0 (en) End stop
EP2348865A4 (en) BETA-HYDROXY-GAMMA-AMINOPHOSPHONATES, THEIR METHODS OF PREPARATION AND THEIR USE
AU2008903436A0 (en) A sulfated polysaccharide compound for clinical use and the preparation and use thereof
GB0717819D0 (en) Polysaccharide fibres
GB0701613D0 (en) The smooth swing
PH32007000238S1 (en) A connector for furnitures and the like
GB0724539D0 (en) Polysaccharides